Skip to the content

MLS® Class IV Therapeutic Laser - M8

M8

The M8 has innovative multi-target functionality, and includes multi diode applicator and standard handpiece. The robotised multi diode applicator allows for automatic treatment of large areas with 5 pre-set directions of movement. It can also be set to automatically treat smaller areas on fixed point application.
The robotised applicator and standard handpiece can be used simultaneously, allowing multiple areas of the body to be treated in one session.

The patented MLS® system delivers pulsed and continuous laser emissions synchronised for the optimal therapeutic effect with wavelengths of 808nm and 905nm. The advanced MLS® laser technology allows true pulsed emissions to achieve peak power of 75 watts, without the risk of thermal damage. 

  • Osteoarthritis
  • Back pain
  • Bursitis
  • Cervical brachialgia
  • Craniofacial pain
  • Oedema
  • Haematoma
  • Joint pain
  • Plantar fasciitis
  • Sprains
  • Strains
  • Tendonitis
  • Trauma
  • Ulcers
  • Wounds
  • Many indications
  • Easy, automatic treatment of large areas
  • Simultaneous use of the robotised applicator and regular handpiece to treat multiple areas
  • Simultaneous therapeutic action - analgesic, anti-inflammatory, anti-oedema
  • MLS® Pulsed combination-synchronisation - 905nm pulsed emissions & 808nm continuous emissions - ensure deep penetration
  • Fast treamtnet times - from 3-10 minutes
  • Reduced number of applications - notable reduction of symptoms from the first session
  • Simultaneous management of two independent channels
  • Robotized optical group with 3 MLS® sources with power up to 3.6 W - Peak Power 3 x 75 W 
    Target Area ø 5 cm highlighted by high-efficiency red LEDs
  • Handpiece with optical group consisting of MLS® source with power up to 1.2 W - Peak Power 75 W 
    Target Area ø 2 cm highlighted by high-efficiency red LEDs
  • High resolution LCD colour touch screen user interface
  • 4 treatment modalities:
    A) pain management
    B) trigger points
    C) anti-edema
    D) biostimulation
  • Possibility to customize every treatment parameters 
  • Dedicated area to create and save new customised programmes for each terminal/applicator
  • MLS® modulation in CPW and FPW mode (synchronized emission of Continuous Pulsed Waves and Frequenced Pulsed Waves)
  • Modulation frequency from 1 to 2000 Hz with 1 Hz steps
  • Power level 25%, 50%, 75% and 100%
  • Fixed duty cycle at 50% or variable
  • Treatment duration from 1” to 44’59’’ with 1” steps
  • Automatic calculation of the emitted energy according to the set parameters

ALARMS AND SAFETY FEATURES

  • Laser emission warning light
  • Interlock
  • Acoustic signal selectable by operator
  • Date and time
  • Password to operate the device
  • Language option
  • Ready to be connected to the remote Laser emission signaling device 

INCLUDED ACCESSORIES

  • Nº 2 Laser Safety Goggles

SIZE AND WEIGHT

  • 106 x 43 x 154 cm
  • 43 Kg

POWER SUPPLY

  • 100/240Vac 50/60Hz 85/100VA

Download the brochure

ASA Catalogue

Each year the ASAcampus (an association between ASAlaser and The University of Florence) publish 'Energy for Health', a scientific magazine focusing on the results of research and clinical studies carried out by internationally renowned researchers, doctors and specialists both in Italy and abroad.

Energy for Health 2022

Energy for Health 2021

Energy for Health 2020

Energy for Health 2019

Energy for Health 2018

Energy for Health 2017

Energy for Health 2016

Energy for Health 2015

Energy for Health 2014

Chow RT, David MA, Armati PJ. 830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: implications for the analgesic effects of 830 nm laser. J Peripher Nerv Syst. 2007 Mar;12(1):28-39.

Simunovic Z. Low level laser therapy with trigger points technique: a clinical study on 243 patients. J Clin Laser Med Surg. 1996 Aug;14(4):163-7.

Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med. 2006 Jan;40(1):76-80; discussion 76-80.

Xavier M, David DR, de Souza RA, Arrieiro AN, Miranda H, Santana ET, Silva JA Jr, Salgado MA, Aimbire F, Albertini R. Anti-inflammatory effects of low-level light emitting diode therapy on Achilles tendinitis in rats. Lasers Surg Med. 2010 Aug;42(6):553-8.

Albertini R, Aimbire F, Villaverde AB, Silva JA Jr, Costa MS. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm Res. 2007 Jun;56(6):228-9.

Kajagar BM, Godhi AS, Pandit A, Khatri S. Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers-a randomised control trial. Indian J Surg. 2012 Oct;74(5):359-63.

Baxter GD, Liu L, Petrich S, Gisselman AS, Chapple C, Anders JJ, Tumilty S. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer. 2017 Dec 7;17(1):833.

Wigg, J. Use and response to treatment using low lovel laser therapy. Journal of Lymphoedema, 2009, Vol 4, No 2.

Medrado AR, Pugliese LS, Reis SR, Andrade ZA. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med. 2003;32(3):239-44.

Fabre HS, Navarro RL, Oltramari-Navarro PV, Oliveira RF, Pires-Oliveira DA, Andraus RA, Fuirini N, Fernandes KB. Anti-inflammatory and analgesic effects of low-level laser therapy on the postoperative healing process. J Phys Ther Sci. 2015 Jun;27(6):1645-1648.

Artés-Ribas M, Arnabat-Dominguez J, Puigdollers A. Analgesic effect of a low-level laser therapy (830 nm) in early orthodontic treatment. Lasers Med Sci. 2013 Jan;28(1):335-41.

Wang P, Liu C, Yang X, Zhou Y, Wei X, Ji Q, Yang L, He C. Effects of low-level laser therapy on joint pain, synovitis, anabolic, and catabolic factors in a progressive osteoarthritis rabbit model. Lasers Med Sci. 2014 Nov;29(6):1875-85.

Prianti AC Jr, Silva JA Jr, Dos Santos RF, Rosseti IB, Costa MS. Low-level laser therapy (LLLT) reduces the COX-2 mRNA expression in both subplantar and total brain tissues in the model of peripheral inflammation induced by administration of carrageenan. Lasers Med Sci. 2014 Jul;29(4):1397-403.

Guerra Fda R, Vieira CP, dos Santos de Almeida M, Oliveira LP, Claro AC, Simões GF, de Oliveira AL, Pimentel ER. Pulsed LLLT improves tendon healing in rats: a biochemical, organizational, and functional evaluation. Lasers Med Sci. 2014 Mar;29(2):805-11.

Training and CPD

All laser purchases come with training to enable you to maximise your clinical results from laser use. 

Find out more

Servicing

All our units require regular servicing, our dedicated team of engineers are able to service units at a time convenient for you to ensure your machine remains in top condition.

Find out more 

Free Trial

Celtic SMR is offering free demonstrations and trials of the ASA Laser so please call us on 0800 279 9050 to find out more.

Contact us

Get in touch about this item

Our expert team will happily help with any questions you may have.

Please select department
Please select profession
The 'First name' field is required
The 'Last name' field is required
Please enter a valid Email address

Get In Touch

Chat with one of our friendly team members today.